nodes	percent_of_prediction	percent_of_DWPC	metapath
Bethanechol—CHRM3—ureter—prostate cancer	0.137	0.681	CbGeAlD
Bethanechol—Lacrimation—Estramustine—prostate cancer	0.0256	0.0367	CcSEcCtD
Bethanechol—Abdominal cramps—Estrone—prostate cancer	0.0213	0.0305	CcSEcCtD
Bethanechol—Micturition urgency—Degarelix—prostate cancer	0.0211	0.0301	CcSEcCtD
Bethanechol—CHRM2—prostate gland—prostate cancer	0.0196	0.0975	CbGeAlD
Bethanechol—Abdominal cramps—Estradiol valerate/Dienogest—prostate cancer	0.0186	0.0266	CcSEcCtD
Bethanechol—Micturition urgency—Bicalutamide—prostate cancer	0.017	0.0243	CcSEcCtD
Bethanechol—Lacrimation increased—Estramustine—prostate cancer	0.0164	0.0234	CcSEcCtD
Bethanechol—CHRM3—prostate gland—prostate cancer	0.0159	0.0794	CbGeAlD
Bethanechol—Micturition urgency—Ethinyl Estradiol—prostate cancer	0.0144	0.0206	CcSEcCtD
Bethanechol—Lacrimation increased—Cabazitaxel—prostate cancer	0.0122	0.0175	CcSEcCtD
Bethanechol—CHRM3—renal system—prostate cancer	0.0109	0.0541	CbGeAlD
Bethanechol—CHRM3—urethra—prostate cancer	0.0107	0.0532	CbGeAlD
Bethanechol—Abdominal cramps—Conjugated Estrogens—prostate cancer	0.00986	0.0141	CcSEcCtD
Bethanechol—Asthma—Estrone—prostate cancer	0.00904	0.0129	CcSEcCtD
Bethanechol—Pollakiuria—Abiraterone—prostate cancer	0.00849	0.0121	CcSEcCtD
Bethanechol—Feeling hot—Conjugated Estrogens—prostate cancer	0.00848	0.0121	CcSEcCtD
Bethanechol—Abdominal cramps—Estradiol—prostate cancer	0.00789	0.0113	CcSEcCtD
Bethanechol—Asthma—Estradiol valerate/Dienogest—prostate cancer	0.00789	0.0113	CcSEcCtD
Bethanechol—Sweating—Nilutamide—prostate cancer	0.00718	0.0103	CcSEcCtD
Bethanechol—Flushing—Estramustine—prostate cancer	0.00703	0.01	CcSEcCtD
Bethanechol—CHRM3—testis—prostate cancer	0.00702	0.035	CbGeAlD
Bethanechol—Pollakiuria—Degarelix—prostate cancer	0.00693	0.0099	CcSEcCtD
Bethanechol—Pollakiuria—Cabazitaxel—prostate cancer	0.00653	0.00933	CcSEcCtD
Bethanechol—Asthma—Bicalutamide—prostate cancer	0.00606	0.00866	CcSEcCtD
Bethanechol—Lacrimation—Docetaxel—prostate cancer	0.00584	0.00834	CcSEcCtD
Bethanechol—Pollakiuria—Bicalutamide—prostate cancer	0.0056	0.008	CcSEcCtD
Bethanechol—Ill-defined disorder—Nilutamide—prostate cancer	0.00543	0.00776	CcSEcCtD
Bethanechol—Ill-defined disorder—Flutamide—prostate cancer	0.0054	0.00772	CcSEcCtD
Bethanechol—Discomfort—Abiraterone—prostate cancer	0.00539	0.0077	CcSEcCtD
Bethanechol—Malaise—Nilutamide—prostate cancer	0.00528	0.00754	CcSEcCtD
Bethanechol—Malaise—Flutamide—prostate cancer	0.00525	0.0075	CcSEcCtD
Bethanechol—Flushing—Cabazitaxel—prostate cancer	0.00525	0.0075	CcSEcCtD
Bethanechol—Sweating—Bicalutamide—prostate cancer	0.00518	0.0074	CcSEcCtD
Bethanechol—Discomfort—Nilutamide—prostate cancer	0.00492	0.00703	CcSEcCtD
Bethanechol—Discomfort—Flutamide—prostate cancer	0.0049	0.007	CcSEcCtD
Bethanechol—Ill-defined disorder—Degarelix—prostate cancer	0.00485	0.00693	CcSEcCtD
Bethanechol—Pollakiuria—Ethinyl Estradiol—prostate cancer	0.00473	0.00676	CcSEcCtD
Bethanechol—Malaise—Degarelix—prostate cancer	0.00471	0.00673	CcSEcCtD
Bethanechol—Hyperhidrosis—Nilutamide—prostate cancer	0.00462	0.0066	CcSEcCtD
Bethanechol—Ill-defined disorder—Cabazitaxel—prostate cancer	0.00457	0.00653	CcSEcCtD
Bethanechol—Malaise—Cabazitaxel—prostate cancer	0.00444	0.00634	CcSEcCtD
Bethanechol—Discomfort—Degarelix—prostate cancer	0.0044	0.00628	CcSEcCtD
Bethanechol—Asthma—Conjugated Estrogens—prostate cancer	0.00418	0.00597	CcSEcCtD
Bethanechol—Discomfort—Cabazitaxel—prostate cancer	0.00414	0.00592	CcSEcCtD
Bethanechol—Hyperhidrosis—Degarelix—prostate cancer	0.00412	0.00589	CcSEcCtD
Bethanechol—Bronchospasm—Conjugated Estrogens—prostate cancer	0.00411	0.00587	CcSEcCtD
Bethanechol—Abdominal pain—Estrone—prostate cancer	0.00406	0.00581	CcSEcCtD
Bethanechol—Hypotension—Degarelix—prostate cancer	0.00399	0.00569	CcSEcCtD
Bethanechol—Lacrimation—Epirubicin—prostate cancer	0.00394	0.00562	CcSEcCtD
Bethanechol—Feeling abnormal—Nilutamide—prostate cancer	0.00393	0.00562	CcSEcCtD
Bethanechol—Tachycardia—Cabazitaxel—prostate cancer	0.00392	0.0056	CcSEcCtD
Bethanechol—Feeling abnormal—Flutamide—prostate cancer	0.00392	0.0056	CcSEcCtD
Bethanechol—Pollakiuria—Goserelin—prostate cancer	0.00389	0.00557	CcSEcCtD
Bethanechol—Abdominal pain—Nilutamide—prostate cancer	0.00377	0.00539	CcSEcCtD
Bethanechol—Hypotension—Cabazitaxel—prostate cancer	0.00375	0.00536	CcSEcCtD
Bethanechol—Lacrimation increased—Docetaxel—prostate cancer	0.00372	0.00532	CcSEcCtD
Bethanechol—Diarrhoea—Estramustine—prostate cancer	0.00368	0.00526	CcSEcCtD
Bethanechol—Lacrimation—Doxorubicin—prostate cancer	0.00364	0.0052	CcSEcCtD
Bethanechol—Lacrimation increased—Capecitabine—prostate cancer	0.0036	0.00515	CcSEcCtD
Bethanechol—Sweating—Goserelin—prostate cancer	0.0036	0.00515	CcSEcCtD
Bethanechol—Diarrhoea—Abiraterone—prostate cancer	0.00358	0.00511	CcSEcCtD
Bethanechol—Abdominal pain—Estradiol valerate/Dienogest—prostate cancer	0.00355	0.00507	CcSEcCtD
Bethanechol—Feeling abnormal—Degarelix—prostate cancer	0.00351	0.00502	CcSEcCtD
Bethanechol—Abdominal pain—Degarelix—prostate cancer	0.00337	0.00482	CcSEcCtD
Bethanechol—Headache—Estramustine—prostate cancer	0.00337	0.00482	CcSEcCtD
Bethanechol—Asthma—Estradiol—prostate cancer	0.00334	0.00478	CcSEcCtD
Bethanechol—Hyperhidrosis—Bicalutamide—prostate cancer	0.00333	0.00476	CcSEcCtD
Bethanechol—Ill-defined disorder—Ethinyl Estradiol—prostate cancer	0.00331	0.00473	CcSEcCtD
Bethanechol—Feeling abnormal—Cabazitaxel—prostate cancer	0.00331	0.00473	CcSEcCtD
Bethanechol—Bronchospasm—Estradiol—prostate cancer	0.00329	0.0047	CcSEcCtD
Bethanechol—Diarrhoea—Nilutamide—prostate cancer	0.00327	0.00467	CcSEcCtD
Bethanechol—Diarrhoea—Flutamide—prostate cancer	0.00325	0.00465	CcSEcCtD
Bethanechol—Headache—Estrone—prostate cancer	0.00322	0.0046	CcSEcCtD
Bethanechol—Malaise—Ethinyl Estradiol—prostate cancer	0.00322	0.0046	CcSEcCtD
Bethanechol—Nausea—Estramustine—prostate cancer	0.0032	0.00457	CcSEcCtD
Bethanechol—Abdominal pain—Cabazitaxel—prostate cancer	0.00318	0.00454	CcSEcCtD
Bethanechol—Pollakiuria—Estradiol—prostate cancer	0.00309	0.00441	CcSEcCtD
Bethanechol—Nausea—Estrone—prostate cancer	0.00305	0.00436	CcSEcCtD
Bethanechol—Discomfort—Ethinyl Estradiol—prostate cancer	0.003	0.00429	CcSEcCtD
Bethanechol—Headache—Nilutamide—prostate cancer	0.00299	0.00427	CcSEcCtD
Bethanechol—Headache—Flutamide—prostate cancer	0.00298	0.00425	CcSEcCtD
Bethanechol—Feeling hot—Epirubicin—prostate cancer	0.00295	0.00421	CcSEcCtD
Bethanechol—Diarrhoea—Degarelix—prostate cancer	0.00292	0.00417	CcSEcCtD
Bethanechol—Feeling abnormal—Bicalutamide—prostate cancer	0.00284	0.00406	CcSEcCtD
Bethanechol—Nausea—Nilutamide—prostate cancer	0.00284	0.00405	CcSEcCtD
Bethanechol—Nausea—Flutamide—prostate cancer	0.00282	0.00403	CcSEcCtD
Bethanechol—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00281	0.00402	CcSEcCtD
Bethanechol—Diarrhoea—Cabazitaxel—prostate cancer	0.00275	0.00393	CcSEcCtD
Bethanechol—Feeling hot—Doxorubicin—prostate cancer	0.00273	0.0039	CcSEcCtD
Bethanechol—Ill-defined disorder—Goserelin—prostate cancer	0.00273	0.00389	CcSEcCtD
Bethanechol—Abdominal pain—Bicalutamide—prostate cancer	0.00272	0.00389	CcSEcCtD
Bethanechol—Headache—Degarelix—prostate cancer	0.00267	0.00382	CcSEcCtD
Bethanechol—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00266	0.00381	CcSEcCtD
Bethanechol—Sweating—Mitoxantrone—prostate cancer	0.00266	0.0038	CcSEcCtD
Bethanechol—Malaise—Goserelin—prostate cancer	0.00265	0.00379	CcSEcCtD
Bethanechol—Bronchospasm—Etoposide—prostate cancer	0.00255	0.00364	CcSEcCtD
Bethanechol—Convulsion—Goserelin—prostate cancer	0.00255	0.00364	CcSEcCtD
Bethanechol—Nausea—Degarelix—prostate cancer	0.00253	0.00362	CcSEcCtD
Bethanechol—Convulsion—Conjugated Estrogens—prostate cancer	0.00252	0.0036	CcSEcCtD
Bethanechol—Headache—Cabazitaxel—prostate cancer	0.00252	0.0036	CcSEcCtD
Bethanechol—Lacrimation increased—Epirubicin—prostate cancer	0.00251	0.00359	CcSEcCtD
Bethanechol—L-Carnitine—MPO—prostate cancer	0.0025	1	CrCbGaD
Bethanechol—Flushing—Estradiol—prostate cancer	0.00248	0.00355	CcSEcCtD
Bethanechol—Discomfort—Goserelin—prostate cancer	0.00247	0.00353	CcSEcCtD
Bethanechol—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.0024	0.00343	CcSEcCtD
Bethanechol—Nausea—Cabazitaxel—prostate cancer	0.00239	0.00341	CcSEcCtD
Bethanechol—Diarrhoea—Bicalutamide—prostate cancer	0.00236	0.00337	CcSEcCtD
Bethanechol—Tachycardia—Goserelin—prostate cancer	0.00234	0.00334	CcSEcCtD
Bethanechol—Lacrimation increased—Doxorubicin—prostate cancer	0.00232	0.00332	CcSEcCtD
Bethanechol—Hyperhidrosis—Goserelin—prostate cancer	0.00232	0.00331	CcSEcCtD
Bethanechol—Tachycardia—Conjugated Estrogens—prostate cancer	0.00232	0.00331	CcSEcCtD
Bethanechol—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.0023	0.00329	CcSEcCtD
Bethanechol—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.0023	0.00328	CcSEcCtD
Bethanechol—Eructation—Epirubicin—prostate cancer	0.00227	0.00325	CcSEcCtD
Bethanechol—Salivary hypersecretion—Epirubicin—prostate cancer	0.00225	0.00321	CcSEcCtD
Bethanechol—Hypotension—Goserelin—prostate cancer	0.00224	0.0032	CcSEcCtD
Bethanechol—Hypotension—Conjugated Estrogens—prostate cancer	0.00222	0.00317	CcSEcCtD
Bethanechol—Ill-defined disorder—Estradiol—prostate cancer	0.00216	0.00309	CcSEcCtD
Bethanechol—Headache—Bicalutamide—prostate cancer	0.00216	0.00309	CcSEcCtD
Bethanechol—Bronchospasm—Docetaxel—prostate cancer	0.00212	0.00303	CcSEcCtD
Bethanechol—Eructation—Doxorubicin—prostate cancer	0.0021	0.00301	CcSEcCtD
Bethanechol—Malaise—Estradiol—prostate cancer	0.0021	0.003	CcSEcCtD
Bethanechol—Asthma—Capecitabine—prostate cancer	0.00208	0.00298	CcSEcCtD
Bethanechol—Salivary hypersecretion—Doxorubicin—prostate cancer	0.00208	0.00297	CcSEcCtD
Bethanechol—Bronchospasm—Capecitabine—prostate cancer	0.00205	0.00293	CcSEcCtD
Bethanechol—Nausea—Bicalutamide—prostate cancer	0.00205	0.00293	CcSEcCtD
Bethanechol—Ill-defined disorder—Mitoxantrone—prostate cancer	0.00201	0.00288	CcSEcCtD
Bethanechol—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00199	0.00285	CcSEcCtD
Bethanechol—Feeling abnormal—Goserelin—prostate cancer	0.00198	0.00282	CcSEcCtD
Bethanechol—Discomfort—Estradiol—prostate cancer	0.00196	0.0028	CcSEcCtD
Bethanechol—Malaise—Mitoxantrone—prostate cancer	0.00196	0.0028	CcSEcCtD
Bethanechol—Flushing—Etoposide—prostate cancer	0.00192	0.00275	CcSEcCtD
Bethanechol—Abdominal pain—Goserelin—prostate cancer	0.0019	0.00271	CcSEcCtD
Bethanechol—Convulsion—Mitoxantrone—prostate cancer	0.00188	0.00269	CcSEcCtD
Bethanechol—Abdominal pain—Conjugated Estrogens—prostate cancer	0.00188	0.00268	CcSEcCtD
Bethanechol—Tachycardia—Estradiol—prostate cancer	0.00185	0.00265	CcSEcCtD
Bethanechol—Hyperhidrosis—Estradiol—prostate cancer	0.00184	0.00263	CcSEcCtD
Bethanechol—Discomfort—Mitoxantrone—prostate cancer	0.00183	0.00261	CcSEcCtD
Bethanechol—Headache—Ethinyl Estradiol—prostate cancer	0.00182	0.00261	CcSEcCtD
Bethanechol—Nausea—Ethinyl Estradiol—prostate cancer	0.00173	0.00247	CcSEcCtD
Bethanechol—Tachycardia—Mitoxantrone—prostate cancer	0.00173	0.00247	CcSEcCtD
Bethanechol—Hyperhidrosis—Mitoxantrone—prostate cancer	0.00171	0.00245	CcSEcCtD
Bethanechol—Ill-defined disorder—Etoposide—prostate cancer	0.00167	0.00239	CcSEcCtD
Bethanechol—Hypotension—Mitoxantrone—prostate cancer	0.00165	0.00236	CcSEcCtD
Bethanechol—Diarrhoea—Goserelin—prostate cancer	0.00164	0.00234	CcSEcCtD
Bethanechol—Malaise—Etoposide—prostate cancer	0.00163	0.00233	CcSEcCtD
Bethanechol—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00162	0.00232	CcSEcCtD
Bethanechol—Flushing—Docetaxel—prostate cancer	0.0016	0.00229	CcSEcCtD
Bethanechol—Feeling abnormal—Estradiol—prostate cancer	0.00157	0.00224	CcSEcCtD
Bethanechol—Convulsion—Etoposide—prostate cancer	0.00156	0.00223	CcSEcCtD
Bethanechol—Flushing—Capecitabine—prostate cancer	0.00155	0.00221	CcSEcCtD
Bethanechol—Discomfort—Etoposide—prostate cancer	0.00152	0.00217	CcSEcCtD
Bethanechol—Abdominal pain—Estradiol—prostate cancer	0.0015	0.00215	CcSEcCtD
Bethanechol—Headache—Goserelin—prostate cancer	0.0015	0.00215	CcSEcCtD
Bethanechol—Headache—Conjugated Estrogens—prostate cancer	0.00149	0.00213	CcSEcCtD
Bethanechol—Feeling abnormal—Mitoxantrone—prostate cancer	0.00146	0.00209	CcSEcCtD
Bethanechol—Asthma—Epirubicin—prostate cancer	0.00145	0.00207	CcSEcCtD
Bethanechol—Tachycardia—Etoposide—prostate cancer	0.00144	0.00205	CcSEcCtD
Bethanechol—Nausea—Goserelin—prostate cancer	0.00142	0.00204	CcSEcCtD
Bethanechol—Hyperhidrosis—Etoposide—prostate cancer	0.00142	0.00203	CcSEcCtD
Bethanechol—Nausea—Conjugated Estrogens—prostate cancer	0.00141	0.00202	CcSEcCtD
Bethanechol—Abdominal pain—Mitoxantrone—prostate cancer	0.0014	0.002	CcSEcCtD
Bethanechol—Flushing—Prednisone—prostate cancer	0.00138	0.00197	CcSEcCtD
Bethanechol—Hypotension—Etoposide—prostate cancer	0.00138	0.00197	CcSEcCtD
Bethanechol—Ill-defined disorder—Capecitabine—prostate cancer	0.00135	0.00193	CcSEcCtD
Bethanechol—Asthma—Doxorubicin—prostate cancer	0.00134	0.00192	CcSEcCtD
Bethanechol—Pollakiuria—Epirubicin—prostate cancer	0.00134	0.00192	CcSEcCtD
Bethanechol—Malaise—Capecitabine—prostate cancer	0.00131	0.00187	CcSEcCtD
Bethanechol—Diarrhoea—Estradiol—prostate cancer	0.0013	0.00186	CcSEcCtD
Bethanechol—Convulsion—Docetaxel—prostate cancer	0.0013	0.00186	CcSEcCtD
Bethanechol—Sweating—Epirubicin—prostate cancer	0.00124	0.00177	CcSEcCtD
Bethanechol—Pollakiuria—Doxorubicin—prostate cancer	0.00124	0.00177	CcSEcCtD
Bethanechol—Discomfort—Capecitabine—prostate cancer	0.00122	0.00175	CcSEcCtD
Bethanechol—Feeling abnormal—Etoposide—prostate cancer	0.00121	0.00173	CcSEcCtD
Bethanechol—Diarrhoea—Mitoxantrone—prostate cancer	0.00121	0.00173	CcSEcCtD
Bethanechol—Ill-defined disorder—Prednisone—prostate cancer	0.0012	0.00172	CcSEcCtD
Bethanechol—Tachycardia—Docetaxel—prostate cancer	0.00119	0.00171	CcSEcCtD
Bethanechol—Headache—Estradiol—prostate cancer	0.00119	0.0017	CcSEcCtD
Bethanechol—Malaise—Prednisone—prostate cancer	0.00117	0.00167	CcSEcCtD
Bethanechol—Abdominal pain—Etoposide—prostate cancer	0.00116	0.00166	CcSEcCtD
Bethanechol—Tachycardia—Capecitabine—prostate cancer	0.00116	0.00165	CcSEcCtD
Bethanechol—Sweating—Doxorubicin—prostate cancer	0.00115	0.00164	CcSEcCtD
Bethanechol—Hyperhidrosis—Capecitabine—prostate cancer	0.00115	0.00164	CcSEcCtD
Bethanechol—Hypotension—Docetaxel—prostate cancer	0.00114	0.00163	CcSEcCtD
Bethanechol—Nausea—Estradiol—prostate cancer	0.00113	0.00161	CcSEcCtD
Bethanechol—Convulsion—Prednisone—prostate cancer	0.00112	0.0016	CcSEcCtD
Bethanechol—Headache—Mitoxantrone—prostate cancer	0.00111	0.00159	CcSEcCtD
Bethanechol—Hypotension—Capecitabine—prostate cancer	0.00111	0.00158	CcSEcCtD
Bethanechol—Discomfort—Prednisone—prostate cancer	0.00109	0.00155	CcSEcCtD
Bethanechol—Flushing—Epirubicin—prostate cancer	0.00108	0.00154	CcSEcCtD
Bethanechol—Nausea—Mitoxantrone—prostate cancer	0.00105	0.0015	CcSEcCtD
Bethanechol—Tachycardia—Prednisone—prostate cancer	0.00103	0.00147	CcSEcCtD
Bethanechol—Hyperhidrosis—Prednisone—prostate cancer	0.00102	0.00146	CcSEcCtD
Bethanechol—Feeling abnormal—Docetaxel—prostate cancer	0.00101	0.00144	CcSEcCtD
Bethanechol—Diarrhoea—Etoposide—prostate cancer	0.00101	0.00144	CcSEcCtD
Bethanechol—Flushing—Doxorubicin—prostate cancer	0.000998	0.00143	CcSEcCtD
Bethanechol—Feeling abnormal—Capecitabine—prostate cancer	0.000977	0.0014	CcSEcCtD
Bethanechol—Abdominal pain—Docetaxel—prostate cancer	0.000968	0.00138	CcSEcCtD
Bethanechol—Ill-defined disorder—Epirubicin—prostate cancer	0.000939	0.00134	CcSEcCtD
Bethanechol—Abdominal pain—Capecitabine—prostate cancer	0.000937	0.00134	CcSEcCtD
Bethanechol—Headache—Etoposide—prostate cancer	0.000923	0.00132	CcSEcCtD
Bethanechol—Malaise—Epirubicin—prostate cancer	0.000912	0.0013	CcSEcCtD
Bethanechol—Convulsion—Epirubicin—prostate cancer	0.000877	0.00125	CcSEcCtD
Bethanechol—Nausea—Etoposide—prostate cancer	0.000875	0.00125	CcSEcCtD
Bethanechol—Feeling abnormal—Prednisone—prostate cancer	0.00087	0.00124	CcSEcCtD
Bethanechol—Ill-defined disorder—Doxorubicin—prostate cancer	0.000869	0.00124	CcSEcCtD
Bethanechol—Discomfort—Epirubicin—prostate cancer	0.000851	0.00122	CcSEcCtD
Bethanechol—Malaise—Doxorubicin—prostate cancer	0.000844	0.00121	CcSEcCtD
Bethanechol—Diarrhoea—Docetaxel—prostate cancer	0.000838	0.0012	CcSEcCtD
Bethanechol—Abdominal pain—Prednisone—prostate cancer	0.000835	0.00119	CcSEcCtD
Bethanechol—Convulsion—Doxorubicin—prostate cancer	0.000811	0.00116	CcSEcCtD
Bethanechol—Diarrhoea—Capecitabine—prostate cancer	0.000811	0.00116	CcSEcCtD
Bethanechol—Tachycardia—Epirubicin—prostate cancer	0.000806	0.00115	CcSEcCtD
Bethanechol—Hyperhidrosis—Epirubicin—prostate cancer	0.000798	0.00114	CcSEcCtD
Bethanechol—Discomfort—Doxorubicin—prostate cancer	0.000787	0.00113	CcSEcCtD
Bethanechol—Hypotension—Epirubicin—prostate cancer	0.000772	0.0011	CcSEcCtD
Bethanechol—Headache—Docetaxel—prostate cancer	0.000767	0.0011	CcSEcCtD
Bethanechol—Tachycardia—Doxorubicin—prostate cancer	0.000746	0.00107	CcSEcCtD
Bethanechol—Headache—Capecitabine—prostate cancer	0.000743	0.00106	CcSEcCtD
Bethanechol—Hyperhidrosis—Doxorubicin—prostate cancer	0.000739	0.00106	CcSEcCtD
Bethanechol—Nausea—Docetaxel—prostate cancer	0.000727	0.00104	CcSEcCtD
Bethanechol—Diarrhoea—Prednisone—prostate cancer	0.000722	0.00103	CcSEcCtD
Bethanechol—Hypotension—Doxorubicin—prostate cancer	0.000714	0.00102	CcSEcCtD
Bethanechol—Nausea—Capecitabine—prostate cancer	0.000704	0.00101	CcSEcCtD
Bethanechol—Feeling abnormal—Epirubicin—prostate cancer	0.00068	0.000972	CcSEcCtD
Bethanechol—Headache—Prednisone—prostate cancer	0.000661	0.000945	CcSEcCtD
Bethanechol—Abdominal pain—Epirubicin—prostate cancer	0.000653	0.000933	CcSEcCtD
Bethanechol—Feeling abnormal—Doxorubicin—prostate cancer	0.00063	0.0009	CcSEcCtD
Bethanechol—Nausea—Prednisone—prostate cancer	0.000627	0.000896	CcSEcCtD
Bethanechol—Abdominal pain—Doxorubicin—prostate cancer	0.000604	0.000863	CcSEcCtD
Bethanechol—Diarrhoea—Epirubicin—prostate cancer	0.000565	0.000807	CcSEcCtD
Bethanechol—Diarrhoea—Doxorubicin—prostate cancer	0.000523	0.000747	CcSEcCtD
Bethanechol—Headache—Epirubicin—prostate cancer	0.000517	0.000739	CcSEcCtD
Bethanechol—Nausea—Epirubicin—prostate cancer	0.00049	0.000701	CcSEcCtD
Bethanechol—Headache—Doxorubicin—prostate cancer	0.000479	0.000684	CcSEcCtD
Bethanechol—Nausea—Doxorubicin—prostate cancer	0.000454	0.000649	CcSEcCtD
Bethanechol—CHRM3—Metabolism—HPGDS—prostate cancer	6.27e-05	0.000646	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP2C19—prostate cancer	6.23e-05	0.000642	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PLCB2—prostate cancer	6.23e-05	0.000642	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—LRP2—prostate cancer	6.23e-05	0.000642	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—ADRB2—prostate cancer	6.21e-05	0.00064	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CX3CL1—prostate cancer	6.17e-05	0.000635	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—P4HB—prostate cancer	6.17e-05	0.000635	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—ADRB2—prostate cancer	6.15e-05	0.000633	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—P4HB—prostate cancer	6.11e-05	0.000629	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CX3CL1—prostate cancer	6.11e-05	0.000629	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ACHE—prostate cancer	6.08e-05	0.000627	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GSTT1—prostate cancer	6.08e-05	0.000627	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—VAV3—prostate cancer	6.05e-05	0.000624	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HIST1H2BG—prostate cancer	6.05e-05	0.000624	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP2A6—prostate cancer	6.01e-05	0.000619	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GRB7—prostate cancer	6e-05	0.000618	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PDE4D—prostate cancer	6e-05	0.000618	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—VAV3—prostate cancer	5.99e-05	0.000618	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HIST1H2BG—prostate cancer	5.99e-05	0.000618	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PDE4D—prostate cancer	5.94e-05	0.000612	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GRB7—prostate cancer	5.94e-05	0.000612	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—ITPR1—prostate cancer	5.87e-05	0.000605	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—AKR1C3—prostate cancer	5.85e-05	0.000603	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HIST1H4H—prostate cancer	5.85e-05	0.000602	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—CXCL8—prostate cancer	5.84e-05	0.000602	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	5.82e-05	0.0006	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PRKACB—prostate cancer	5.82e-05	0.000599	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—ITPR1—prostate cancer	5.81e-05	0.000599	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HIST1H4H—prostate cancer	5.79e-05	0.000596	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—CXCL8—prostate cancer	5.79e-05	0.000596	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP17A1—prostate cancer	5.76e-05	0.000593	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GNG5—prostate cancer	5.71e-05	0.000588	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GNG5—prostate cancer	5.65e-05	0.000582	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—NCOA2—prostate cancer	5.49e-05	0.000565	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—SLC5A5—prostate cancer	5.23e-05	0.000539	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP2E1—prostate cancer	5.11e-05	0.000527	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—NQO1—prostate cancer	5.05e-05	0.000521	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—TH—prostate cancer	4.98e-05	0.000513	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TGFBR1—prostate cancer	4.97e-05	0.000512	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PTHLH—prostate cancer	4.97e-05	0.000512	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP3A4—prostate cancer	4.93e-05	0.000508	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PTHLH—prostate cancer	4.92e-05	0.000507	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TGFBR1—prostate cancer	4.92e-05	0.000507	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AKR1C3—prostate cancer	4.89e-05	0.000504	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PRKACB—prostate cancer	4.86e-05	0.000501	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP1B1—prostate cancer	4.85e-05	0.000499	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AKR1C3—prostate cancer	4.84e-05	0.000499	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PRKACB—prostate cancer	4.82e-05	0.000496	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—THBS1—prostate cancer	4.74e-05	0.000489	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PPP3CA—prostate cancer	4.74e-05	0.000489	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—THBS1—prostate cancer	4.7e-05	0.000484	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PPP3CA—prostate cancer	4.7e-05	0.000484	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GGT1—prostate cancer	4.69e-05	0.000484	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ANXA1—prostate cancer	4.67e-05	0.000481	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ANXA1—prostate cancer	4.63e-05	0.000477	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—NCOA1—prostate cancer	4.62e-05	0.000476	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PRKCZ—prostate cancer	4.59e-05	0.000473	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP19A1—prostate cancer	4.56e-05	0.000469	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PRKCZ—prostate cancer	4.54e-05	0.000468	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CG—prostate cancer	4.48e-05	0.000462	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CG—prostate cancer	4.44e-05	0.000457	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FGFR4—prostate cancer	4.43e-05	0.000456	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PARP1—prostate cancer	4.43e-05	0.000456	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—RXRA—prostate cancer	4.4e-05	0.000453	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PARP1—prostate cancer	4.39e-05	0.000452	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FGFR4—prostate cancer	4.39e-05	0.000452	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CALCA—prostate cancer	4.38e-05	0.000451	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CALCA—prostate cancer	4.33e-05	0.000446	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CXCL12—prostate cancer	4.27e-05	0.00044	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—COMT—prostate cancer	4.24e-05	0.000436	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CXCL12—prostate cancer	4.23e-05	0.000436	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GSTP1—prostate cancer	4.22e-05	0.000434	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ITPR1—prostate cancer	4.15e-05	0.000427	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CG—prostate cancer	4.07e-05	0.00042	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CG—prostate cancer	4.03e-05	0.000415	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CASP9—prostate cancer	4.03e-05	0.000415	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CASP9—prostate cancer	3.99e-05	0.000411	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CD—prostate cancer	3.94e-05	0.000406	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—TYMS—prostate cancer	3.92e-05	0.000404	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CD—prostate cancer	3.9e-05	0.000402	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NGFR—prostate cancer	3.9e-05	0.000402	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PRKCQ—prostate cancer	3.9e-05	0.000402	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GSTM1—prostate cancer	3.87e-05	0.000399	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PRKCQ—prostate cancer	3.86e-05	0.000398	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NGFR—prostate cancer	3.86e-05	0.000398	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MAP3K7—prostate cancer	3.85e-05	0.000397	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MAP3K7—prostate cancer	3.82e-05	0.000393	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—LPL—prostate cancer	3.8e-05	0.000392	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FGF10—prostate cancer	3.71e-05	0.000382	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP1A1—prostate cancer	3.67e-05	0.000378	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FGF10—prostate cancer	3.67e-05	0.000378	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ADRB2—prostate cancer	3.67e-05	0.000378	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ERCC2—prostate cancer	3.64e-05	0.000375	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ADRB2—prostate cancer	3.63e-05	0.000374	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—JAK2—prostate cancer	3.62e-05	0.000373	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—MAP2K1—prostate cancer	3.6e-05	0.000371	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—JAK2—prostate cancer	3.58e-05	0.000369	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CD—prostate cancer	3.58e-05	0.000369	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—VAV3—prostate cancer	3.58e-05	0.000368	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—MAP2K1—prostate cancer	3.57e-05	0.000368	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CD—prostate cancer	3.54e-05	0.000365	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—VAV3—prostate cancer	3.54e-05	0.000365	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TGFBR2—prostate cancer	3.53e-05	0.000363	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	3.49e-05	0.00036	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ITPR1—prostate cancer	3.47e-05	0.000357	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CB—prostate cancer	3.44e-05	0.000354	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ITPR1—prostate cancer	3.43e-05	0.000354	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—MTHFR—prostate cancer	3.42e-05	0.000353	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	3.4e-05	0.000351	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PPARA—prostate cancer	3.36e-05	0.000346	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IGF1R—prostate cancer	3.32e-05	0.000342	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—CXCL8—prostate cancer	3.3e-05	0.00034	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—JAK2—prostate cancer	3.29e-05	0.000338	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IGF1R—prostate cancer	3.28e-05	0.000338	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	3.27e-05	0.000337	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—JAK2—prostate cancer	3.25e-05	0.000335	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—LPL—prostate cancer	3.18e-05	0.000328	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CAV1—prostate cancer	3.16e-05	0.000325	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—IL2—prostate cancer	3.16e-05	0.000325	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PDGFRB—prostate cancer	3.15e-05	0.000325	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—LPL—prostate cancer	3.15e-05	0.000324	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—IL2—prostate cancer	3.12e-05	0.000322	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	3.12e-05	0.000322	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CB—prostate cancer	3.12e-05	0.000321	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	3.09e-05	0.000318	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ITGB3—prostate cancer	3.07e-05	0.000316	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ITGB3—prostate cancer	3.04e-05	0.000313	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—CXCL8—prostate cancer	3e-05	0.000309	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ERBB3—prostate cancer	2.98e-05	0.000307	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FGFR2—prostate cancer	2.97e-05	0.000306	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	2.97e-05	0.000306	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ERBB3—prostate cancer	2.95e-05	0.000304	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FGFR2—prostate cancer	2.95e-05	0.000303	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CG—prostate cancer	2.88e-05	0.000296	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—IL2—prostate cancer	2.87e-05	0.000295	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TERT—prostate cancer	2.85e-05	0.000294	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—IL2—prostate cancer	2.84e-05	0.000292	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TERT—prostate cancer	2.83e-05	0.000291	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HIF1A—prostate cancer	2.73e-05	0.000281	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—INS—prostate cancer	2.72e-05	0.000281	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HIF1A—prostate cancer	2.7e-05	0.000279	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CREBBP—prostate cancer	2.67e-05	0.000275	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—LEP—prostate cancer	2.67e-05	0.000275	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CAV1—prostate cancer	2.64e-05	0.000272	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—LEP—prostate cancer	2.64e-05	0.000272	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CAV1—prostate cancer	2.62e-05	0.000269	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—KDR—prostate cancer	2.61e-05	0.000269	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—KDR—prostate cancer	2.59e-05	0.000266	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ESR1—prostate cancer	2.54e-05	0.000262	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CD—prostate cancer	2.53e-05	0.000261	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ESR1—prostate cancer	2.52e-05	0.00026	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—BAD—prostate cancer	2.48e-05	0.000256	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—BAD—prostate cancer	2.46e-05	0.000253	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CG—prostate cancer	2.41e-05	0.000248	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—APC—prostate cancer	2.41e-05	0.000248	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—NOS3—prostate cancer	2.39e-05	0.000246	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	2.38e-05	0.000245	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—APC—prostate cancer	2.38e-05	0.000245	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IRS1—prostate cancer	2.38e-05	0.000245	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EGF—prostate cancer	2.38e-05	0.000245	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IRS1—prostate cancer	2.35e-05	0.000243	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EGF—prostate cancer	2.35e-05	0.000243	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GSK3B—prostate cancer	2.31e-05	0.000238	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GSK3B—prostate cancer	2.29e-05	0.000235	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—INS—prostate cancer	2.28e-05	0.000235	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—INS—prostate cancer	2.25e-05	0.000232	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CREBBP—prostate cancer	2.23e-05	0.00023	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CREBBP—prostate cancer	2.21e-05	0.000228	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CB—prostate cancer	2.2e-05	0.000227	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IGF1—prostate cancer	2.2e-05	0.000227	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—EGFR—prostate cancer	2.19e-05	0.000226	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PTGS2—prostate cancer	2.18e-05	0.000225	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IGF1—prostate cancer	2.18e-05	0.000225	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—EGFR—prostate cancer	2.17e-05	0.000224	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MAP2K1—prostate cancer	2.13e-05	0.000219	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CD—prostate cancer	2.11e-05	0.000218	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	2.11e-05	0.000217	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CA—prostate cancer	2.09e-05	0.000216	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	2.09e-05	0.000216	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	2.09e-05	0.000215	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	2.07e-05	0.000214	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	2.07e-05	0.000213	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—KRAS—prostate cancer	2.07e-05	0.000213	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—KRAS—prostate cancer	2.05e-05	0.000211	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FGF2—prostate cancer	2.02e-05	0.000209	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FGF2—prostate cancer	2e-05	0.000207	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NOS3—prostate cancer	2e-05	0.000206	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NOS3—prostate cancer	1.98e-05	0.000204	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—JAK2—prostate cancer	1.94e-05	0.0002	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—JAK2—prostate cancer	1.92e-05	0.000198	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PTEN—prostate cancer	1.9e-05	0.000196	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	1.9e-05	0.000196	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MDM2—prostate cancer	1.89e-05	0.000195	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	1.88e-05	0.000194	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MDM2—prostate cancer	1.88e-05	0.000193	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ERBB2—prostate cancer	1.87e-05	0.000192	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ERBB2—prostate cancer	1.85e-05	0.000191	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	1.84e-05	0.00019	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	1.83e-05	0.000188	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—EP300—prostate cancer	1.82e-05	0.000187	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CXCL8—prostate cancer	1.77e-05	0.000182	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CXCL8—prostate cancer	1.75e-05	0.000181	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	1.73e-05	0.000178	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	1.71e-05	0.000176	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	1.71e-05	0.000176	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CASP3—prostate cancer	1.7e-05	0.000175	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	1.69e-05	0.000175	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IL2—prostate cancer	1.69e-05	0.000174	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—IL6—prostate cancer	1.68e-05	0.000174	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CASP3—prostate cancer	1.68e-05	0.000173	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IL2—prostate cancer	1.68e-05	0.000173	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—IL6—prostate cancer	1.67e-05	0.000172	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CCND1—prostate cancer	1.65e-05	0.00017	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	1.63e-05	0.000168	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CCND1—prostate cancer	1.63e-05	0.000168	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	1.62e-05	0.000167	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MMP9—prostate cancer	1.6e-05	0.000165	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	1.6e-05	0.000164	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PTEN—prostate cancer	1.59e-05	0.000164	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MMP9—prostate cancer	1.59e-05	0.000163	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	1.58e-05	0.000163	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PTEN—prostate cancer	1.58e-05	0.000162	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—AKT1—prostate cancer	1.55e-05	0.00016	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—AKT1—prostate cancer	1.54e-05	0.000159	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EP300—prostate cancer	1.52e-05	0.000156	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EP300—prostate cancer	1.5e-05	0.000155	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SRC—prostate cancer	1.48e-05	0.000152	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SRC—prostate cancer	1.46e-05	0.000151	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—VEGFA—prostate cancer	1.44e-05	0.000148	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—VEGFA—prostate cancer	1.42e-05	0.000147	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—STAT3—prostate cancer	1.42e-05	0.000147	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—STAT3—prostate cancer	1.41e-05	0.000145	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CA—prostate cancer	1.34e-05	0.000138	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MYC—prostate cancer	1.32e-05	0.000136	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TGFB1—prostate cancer	1.32e-05	0.000136	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MYC—prostate cancer	1.31e-05	0.000135	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TGFB1—prostate cancer	1.31e-05	0.000135	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EGFR—prostate cancer	1.29e-05	0.000133	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EGFR—prostate cancer	1.28e-05	0.000132	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—KRAS—prostate cancer	1.22e-05	0.000126	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—KRAS—prostate cancer	1.21e-05	0.000125	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	1.12e-05	0.000116	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	1.11e-05	0.000115	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—AKT1—prostate cancer	1.1e-05	0.000113	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TP53—prostate cancer	1.09e-05	0.000112	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TP53—prostate cancer	1.08e-05	0.000111	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IL6—prostate cancer	9.95e-06	0.000103	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IL6—prostate cancer	9.85e-06	0.000102	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AKT1—prostate cancer	9.18e-06	9.46e-05	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AKT1—prostate cancer	9.09e-06	9.36e-05	CbGpPWpGaD
